SERUM INTERLEUKIN-6 LEVELS DURING TREATMENT CORRELATE WITH RESISTANCE TO TELAPREVIR-BASED TRIPLE THERAPY IN CHRONIC HEPATITIS C

被引：1
|
作者：
Asahina, Y. [1 ,2 ]
Nakagawa, M. [1 ]
Taniguchi, M. [1 ]
Kawai, F. [1 ]
Fujiki, J. [1 ]
Otani, T. [1 ]
Yamanaka, H. [1 ]
Murakawa, M. [1 ]
Nitta, S. [1 ]
Kitazume, A. [1 ]
Watanabe, T. [1 ]
Sakurai, Y. [1 ]
Azuma, S. [1 ]
Kakinuma, S. [1 ,2 ]
Watanabe, M. [1 ]
机构：
[1] Tokyo Med & Dent Univ, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Dept Hepatits Control, Tokyo, Japan
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60791-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
789
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [1] Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
    Kohjima, Motoyuki
    Kurokawa, Miho
    Enjoji, Munechika
    Yoshimoto, Tsuyoshi
    Nakamura, Tsukasa
    Ohashi, Tomoko
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Murata, Yusuke
    Matsunaga, Kazuhisa
    Kato, Masaki
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1781 - 1787
  • [2] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
  • [3] Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan
    Shiraishi, Muneshige
    Umebayashi, Itsuro
    Matsuda, Hiroaki
    Sawamura, Keisuke
    Okada, Aiko
    Karino, Masako
    Nogami, Yoshihide
    HEPATOLOGY RESEARCH, 2015, 45 (13) : 1267 - 1275
  • [4] Improvement of Liver Stiffness Measured by ARFI During Telaprevir-Based Triple Therapy for Chronic Hepatitis C
    Kanata, Ryo
    Goto, Takashi
    Miura, Kouichi
    Ohshima, Shigetoshi
    Shibuya, Tomomi
    Sato, Wataru
    Kamada, Kentaro
    Chiba, Mitsuru
    Sakai, Toshitaka
    Minami, Shinichiro
    Sugimoto, Yuko
    Fujiwara, Junichi
    Ishioka, Mitsuaki
    Ohnishi, Hirohide
    GASTROENTEROLOGY, 2014, 146 (05) : S261 - S261
  • [5] Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
    Kondo, C.
    Atsukawa, M.
    Tsubota, A.
    Shimada, N.
    Abe, H.
    Aizawa, Y.
    JOURNAL OF POSTGRADUATE MEDICINE, 2016, 62 (01) : 20 - 25
  • [6] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    T. Tieghi
    R. Marocco
    V. Belvisi
    C. Del Borgo
    S. Savinelli
    M. Lichtner
    C. M. Mastroianni
    Infection, 2014, 42 : 225 - 226
  • [7] The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying
    Arai, Makoto
    Oyamada, Arata
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kanda, Tastuo
    Katsuno, Tatsuro
    Imazeki, Fumio
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2014, 146 (05) : S615 - S616
  • [8] Effect of telaprevir-based triple therapy on the renal function of chronic hepatitis C patients
    Ozeki, Itaru
    Nakzima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    HEPATOLOGY, 2012, 56 : 1040A - 1040A
  • [9] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    Tieghi, T.
    Marocco, R.
    Belvisi, V.
    Del Borgo, C.
    Savinelli, S.
    Lichtner, M.
    Mastroianni, C. M.
    INFECTION, 2014, 42 (01) : 225 - 226
  • [10] VIROLOGICAL RESPONSE AT WEEK 6 OF TELAPREVIR-BASED TRIPLE THERAPY IS THE MOST EFFECTIVE PREDICTOR OF CHRONIC HEPATITIS C TREATMENT OUTCOME
    Hiramine, S.
    Ogawa, E.
    Furusyo, N.
    Nakamura, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S474 - S474
12345